Predict your next investment

Corporation
HEALTHCARE | Medical Equipment & Supplies
cantelmedical.com

See what CB Insights has to offer

Partners & Customers

2

Service Providers

3

About Cantel

Cantel (NYSE: CMN) provides infection prevention and control products in the healthcare market. The company's products include water purification equipment, sterilants, disinfectants and cleaners, specialized medical device reprocessing systems for endoscopy and renal dialysis, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates and other dialysis supplies, hollow fiber membrane filtration, and separation products for medical and non-medical applications and specialty packaging for infectious and biological specimens. Cantel also provides technical maintenance for its products and offers compliance training services for the transport of infectious and biological specimens.On June 2nd, 2021, Cantel was acquired by Steris at a valuation of $3600M.

Cantel Headquarter Location

150 Clove Road 9th Floor

Little Falls, New Jersey, 07424,

United States

973-890-7220

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Cantel

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Cantel in 1 CB Insights research brief, most recently on Jul 31, 2019.

Latest Cantel News

Instrument Cleaners and Detergents Market is Projected to Grow at 4.1% CAGR Between 2021-2031

May 19, 2022

Instrument Cleaners and Detergents Market is Projected to Grow at 4.1% CAGR Between 2021-2031 Increase in incidence of hospital-acquired infections is enabling growth in the  instrument cleaners and detergents market , which is expected to reach US$ 2.02 Bn in 2021. The market is projected to register growth at a positive pace between 2021 and 2031, driven by the increasing occurrence of hospital-acquired infections (HAIs). Hospital-acquired infections have emerged as a key health concern, influencing patient recovery that has a significant effect on mortality recorded worldwide. In addition, the increase in the occurrence of surgical site infections is expected to drive the market. Click to get Sample @ Hospitals utilize various medical instruments during the course of treatment and diagnosis of the patients. These medical instruments ought to be disinfected and cleaned on daily basis which requires the detergents and cleaners. Apart from this, rising cases of chronic diseases, growing overall population, and improving medical care awareness among general people are some of the primary reasons driving the instrument cleaners and detergents market. Spurred by favorable trends, some of the leading pharmaceutical companies are focusing on expanding their product scope across various distribution channels. Currently, the market can be broadly categorized into cleaners and detergents in terms of products. Of these, detergents are forecast to account for over 73% of sales in the market by 2031. Rising demand from hospitals and various other healthcare institutions will remain a chief growth driver. Amid COVID-19 outbreak, focus on sanitization is at all-time high. This has caused the sales of instrument cleaners and detergents to soar as well. Key Participant Insights The instrument cleaners and detergents market is set to expand in the forecast period, as a result of rising prevalence of various infectious diseases, and growing investment in R&D. Some of the leading companies are actively engaging into acquisitions and expansion in order to enhance their product portfolio and outreach. The key market players covered by FMI include Metrex Research, LLC , Ruhof Corporation, Case Medical, Inc., Certol International LLC, Dr. Weigert, Biotrol, ORO Clean Chemie AG, Medalkan, STERIS Plc, Getinge Group, Ecolab Inc., 3M Co., Cantel Medical Corporation, EQT (Schülke & Mayr GmbH), Fortive Corporation (Advanced Sterilization Products) and Medline Industries, Inc. Who is Winning? Some of the leading players operating in the market are concentrating on rising acquisitions at territorial levels. The pattern is mainly seen across Europe and North America. Acquisitions offer organizations the scope to expand portfolio. It is therefore one of the key strategies adopted by the market players to strengthen their footprint. For instance: In, January 2021, STERIS Plc and Cantel Medical Corp  announced that STERIS has signed a definitive agreement to acquire Cantel, through a U.S. subsidiary. Cantel is a global provider of infection-prevention products and services, primarily to endoscopy and dental Customers. In December 2020, CANTEL MEDICAL CORP. and Censis Technologies announced a new long-term partnership to combine Cantel’s leading infection-prevention endoscope reprocessing workflow portfolio with the surgical asset management and instrument tracking solutions from Censis. Key Takeaways from Instrument Cleaners and Detergents Market Study Instrument cleaners and detergents market will register 4.1% CAGR between 2021 and 2031, thanks to higher focus on curbing the incidence of infection in healthcare institutions Demand from hospitals will continue rising. Hospitals are likely to emerge as dominant end user and reach a market value of US$ 1.1 Bn by 2031 The U.S. is the most lucrative market in the global instrument cleaners and detergents market and is expected to grow at a CAGR of 4.4% between 2021 and 2031 After a period of positive growth, the demand will drop slightly in the U.K. In 2021, the U.K. market is expected to register 3.7% y-o-y growth China and Japan are likely to dominate sales registered in East Asia Get Valuable Insights into Instrument Cleaners and Detergents Market Future Market Insights, in its new offering, provides an unbiased analysis of the instrument cleaners and detergents market, presenting historical demand data (2016-2020) and forecast statistics for the period from (2021-2031). The study divulges compelling insights into the market in terms of product type (cleaners and detergents), by process type (pre-soak, manual cleaning, automatic cleaning, and disinfection), instrument type (surgical instruments, endoscopes, ultrasound, and dental instruments), and end user (hospitals, ambulatory surgical centers, diagnostic centers, and specialty clinics), and across major regions. Click to get the in-depth TOC of this Report @  https://www.futuremarketinsights.com/reports/instrument-cleaners-and-detergents-market/table-of-content About Future Market Insights (FMI) Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years Contact Us:

Cantel Acquisitions

17 Acquisitions

Cantel acquired 17 companies. Their latest acquisition was Hu-Friedy on July 30, 2019.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

7/30/2019

$99M

Acquired

2

1/11/2019

$99M

Acquired

2

11/12/2018

$99M

Acquired

3

11/12/2018

Subscribe to see more

$99M

Subscribe to see more

10

8/3/2018

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/30/2019

1/11/2019

11/12/2018

11/12/2018

8/3/2018

Investment Stage

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

Note

Acquired

Acquired

Acquired

Subscribe to see more

Subscribe to see more

Sources

2

2

3

10

10

Cantel Partners & Customers

2 Partners and customers

Cantel has 2 strategic partners and customers. Cantel recently partnered with Censis Technologies on December 12, 2020.

Date

Type

Business Partner

Country

News Snippet

Sources

12/7/2020

Partner

United States

Censis Technologies and Cantel Medical Enter into Partnership to Develop Differentiated Endoscope Reprocessing Software Solution.

The new enhanced , co-branded software solution will combine the CANEXIS ™ Integrated Workflow Solution for Endoscopy from Cantel with Censis Technologies ' CensiTrac ™ surgical asset management software to create the leading instrument reprocessing and scope tracking software available to the market .

3

2/10/2020

Partner

United Kingdom

Subscribe to see more

Subscribe to see more

10

Date

12/7/2020

2/10/2020

Type

Partner

Partner

Business Partner

Country

United States

United Kingdom

News Snippet

Censis Technologies and Cantel Medical Enter into Partnership to Develop Differentiated Endoscope Reprocessing Software Solution.

The new enhanced , co-branded software solution will combine the CANEXIS ™ Integrated Workflow Solution for Endoscopy from Cantel with Censis Technologies ' CensiTrac ™ surgical asset management software to create the leading instrument reprocessing and scope tracking software available to the market .

Subscribe to see more

Subscribe to see more

Sources

3

10

Cantel Service Providers

3 Service Providers

Cantel has 3 service provider relationships

Service Provider

Associated Rounds

Provider Type

Service Type

Acq - P2P

Management Consultants

Financial Advisor

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Service Provider

Subscribe to see more

Subscribe to see more

Associated Rounds

Acq - P2P

Subscribe to see more

Subscribe to see more

Provider Type

Management Consultants

Subscribe to see more

Subscribe to see more

Service Type

Financial Advisor

Subscribe to see more

Subscribe to see more

Partnership data by VentureSource

Cantel Team

9 Team Members

Cantel has 9 team members, including former Chief Executive Officer, President, Chief Operating Officer, Executive Vice President, Jørgen Bundgaard Hansen.

Name

Work History

Title

Status

Jørgen Bundgaard Hansen

ConvaTec, and Coloplast

Chief Executive Officer, President, Chief Operating Officer, Executive Vice President

Former

Andrew A. Krakauer

Chief Executive Officer

Former

William Poole

Chief Executive Officer, President

Former

David Hemink

President

Former

R Scott Jones

President

Former

Name

Jørgen Bundgaard Hansen

Andrew A. Krakauer

William Poole

David Hemink

R Scott Jones

Work History

ConvaTec, and Coloplast

Title

Chief Executive Officer, President, Chief Operating Officer, Executive Vice President

Chief Executive Officer

Chief Executive Officer, President

President

President

Status

Former

Former

Former

Former

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.